3 US Blue Chip Earnings Reports You Can’t Miss

July and August were busy months, with many US companies announcing their latest results. Amidst the flood of earnings reports, you may have missed some notable results. We’ll highlight some of the blue chips that showed strong earnings growth and provided promising guidance.

Eli Lilly (NYSE: LLY)

The world’s largest healthcare company delivered yet again. In the second quarter of 2024 (Q2 2024), Eli Lilly showed why it remains the clear leader in healthcare. Eli Lilly announced a 36.0% year-over-year increase in revenue, from $8.3 billion to $11.3 billion. Even more impressively, net income increased 68.3% year-over-year to $3.0 billion. The company attributed its solid revenue growth to higher sales volumes, driven by the success of its diabetes and cancer drugs. Most importantly, Eli Lilly saw strong demand for its drug Mounjaro, which is known for its “cosmetic weight loss” potential, despite the company’s attempts to discourage such uses….